EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 105 filers reported holding EPIZYME INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $37,000 | +5.7% | 25,338 | +81.7% | 0.00% | 0.0% |
| Q4 2021 | $35,000 | -73.1% | 13,948 | +27.6% | 0.00% | -87.5% |
| Q3 2020 | $130,000 | -78.9% | 10,934 | -56.3% | 0.01% | -84.9% |
| Q4 2019 | $615,000 | +3.2% | 25,000 | -47.3% | 0.05% | -1.9% |
| Q2 2019 | $596,000 | +67.4% | 47,474 | +41.3% | 0.05% | +54.3% |
| Q3 2018 | $356,000 | -34.9% | 33,592 | -7.2% | 0.04% | -69.3% |
| Q2 2017 | $547,000 | – | 36,182 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |